275 related articles for article (PubMed ID: 17375800)
1. Metabolic syndrome: controversial but useful.
Stolar M
Cleve Clin J Med; 2007 Mar; 74(3):199-202, 205-8. PubMed ID: 17375800
[TBL] [Abstract][Full Text] [Related]
2. Dyslipidemia in the metabolic syndrome in children.
Gidding SS
J Cardiometab Syndr; 2006; 1(4):282-5. PubMed ID: 17679808
[TBL] [Abstract][Full Text] [Related]
3. Effect of body mass index on insulin resistance and lipids in prepubertal and postpubertal children: SCHOOL observations.
Murdock DK; Olson KJ; Juza RM; Hendricks BL
J Cardiometab Syndr; 2006; 1(4):242-7. PubMed ID: 17679804
[TBL] [Abstract][Full Text] [Related]
4. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
Nesto RW
Am J Cardiovasc Drugs; 2005; 5(6):379-87. PubMed ID: 16259526
[TBL] [Abstract][Full Text] [Related]
5. Metabolic syndrome.
Opie LH
Circulation; 2007 Jan; 115(3):e32-5. PubMed ID: 17242286
[No Abstract] [Full Text] [Related]
6. Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview.
Amihăesei IC; Chelaru L
Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):896-900. PubMed ID: 25581945
[TBL] [Abstract][Full Text] [Related]
7. [Treatment principles for the metabolic syndrome].
Boulogne A; Vantyghem MC
Presse Med; 2004 Jun; 33(10):673-81. PubMed ID: 15257242
[TBL] [Abstract][Full Text] [Related]
8. Implications of the obesity epidemic for lipid-lowering therapy: non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target.
Hoenig MR
Vasc Health Risk Manag; 2008; 4(1):143-56. PubMed ID: 18629364
[TBL] [Abstract][Full Text] [Related]
9. The metabolic syndrome: an emerging health epidemic in women.
Steinbaum SR
Prog Cardiovasc Dis; 2004; 46(4):321-36. PubMed ID: 14961455
[TBL] [Abstract][Full Text] [Related]
10. [Obesity and cardiovascular morbidity].
Berg A; Bönner G
Dtsch Med Wochenschr; 2005 Apr; 130(14):893-7. PubMed ID: 15800824
[No Abstract] [Full Text] [Related]
11. Dyslipidaemia, hypercoagulability and the metabolic syndrome.
Kakafika AI; Liberopoulos EN; Karagiannis A; Athyros VG; Mikhailidis DP
Curr Vasc Pharmacol; 2006 Jul; 4(3):175-83. PubMed ID: 16842135
[TBL] [Abstract][Full Text] [Related]
12. Multiple risk factors for cardiovascular disease and diabetes mellitus.
Smith SC
Am J Med; 2007 Mar; 120(3 Suppl 1):S3-S11. PubMed ID: 17320520
[TBL] [Abstract][Full Text] [Related]
13. [Cardiovascular risk and cardiometabolic risk: an epidemiological evaluation].
Vanuzzo D; Pilotto L; Mirolo R; Pirelli S
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):6S-17S. PubMed ID: 18773746
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of cardiovascular risk factors in coronary heart disease patients with different low-density lipoprotein phenotypes].
Slapikas R; Luksiene D; Slapikiene B; Babarskiene MR; Grybauskiene R; Linoniene L
Medicina (Kaunas); 2005; 41(11):925-31. PubMed ID: 16333215
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome is strongly associated with chronic subclinical inflammation in patients achieving optimal low-density lipoprotein-cholesterol levels in secondary prevention of cardiovascular disease.
Matsuo Y; Hashizume T; Shioji S; Akasaka T
Circ J; 2008 Dec; 72(12):2046-50. PubMed ID: 18946171
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular disease under the influence of excess visceral fat.
Després JP
Crit Pathw Cardiol; 2007 Jun; 6(2):51-9. PubMed ID: 17667865
[TBL] [Abstract][Full Text] [Related]
17. Successful control of dyslipidemia in patients with metabolic syndrome: focus on lifestyle changes.
Stone NJ
Clin Cornerstone; 2006; 8 Suppl 1():S15-20. PubMed ID: 16903165
[TBL] [Abstract][Full Text] [Related]
18. [Diabetic dyslipidaemia and the atherosclerosis].
Márk L; Dani G
Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
[TBL] [Abstract][Full Text] [Related]
19. Effect of high-dose atorvastatin on the cardiovascular risk associated with individual components of metabolic syndrome: a subanalysis of the Treating to New Targets (TNT) study.
Deedwania PC; Shepherd J; Breazna A; DeMicco DA;
Diabetes Obes Metab; 2016 Jan; 18(1):56-63. PubMed ID: 26434404
[TBL] [Abstract][Full Text] [Related]
20. Healthy Lifestyle Characteristics and Their Joint Association With Cardiovascular Disease Biomarkers in US Adults.
Loprinzi PD; Branscum A; Hanks J; Smit E
Mayo Clin Proc; 2016 Apr; 91(4):432-42. PubMed ID: 26906650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
